Dr. David Sinclair: The First Human Trial of an Age-Reversal Therapy #podcast #lifespan #longevity
James AltucherJuly 06, 2026

Dr. David Sinclair: The First Human Trial of an Age-Reversal Therapy #podcast #lifespan #longevity

Harvard geneticist David Sinclair returns to explain how his lab's age-reversal technology has moved from mice and primates into FDA-cleared human trials β€” starting with an attempt to reverse vision loss from glaucoma, a condition considered permanent. Sinclair breaks down the science of Yamanaka factors, why using three genes instead of four sidesteps the cancer risk, and his core thesis: make the body young enough and it can cure its own diseases.

He and James also go deep on the practical longevity playbook: NMN, NAD and Sirtuins, metformin and berberine, testosterone and muscle mass, sleep, diet, and how to separate real science from longevity misinformation. Sinclair shares his own protocol at 56, his 86-year-old father's results, and teases a next-generation "rejuvenation in a pill" molecule his lab hopes to test in humans.

Note: Sinclair discusses early-stage, in-trial, and animal-model research. His forward-looking claims are his own and are not yet proven in humans. Nothing here is medical advice β€” talk to a physician before changing any supplement or medication.

In this episode:
1. How age-reversal tech reached FDA-cleared human trials, starting with the eye
2. What Yamanaka factors are and why they act as a "factory reset" for cells
3. Why three genes (OSK) reverse aging ~75% without triggering cancer
4. The built-in antibiotic "on/off" safety switch behind the therapy
5. Why reversing the age of tissue may let the body cure disease at its source
6. The realistic timeline, cost problem, and path from eye injections to a pill
7. Sinclair's take on NMN, NAD, metformin, berberine, testosterone, and sleep
8. What's next after glaucoma: liver, joints, skin, and a next-gen molecule

Timestamps:
0:00 – Aging as a disease we could cure
2:00 – Reversing aging in the eye to treat glaucoma (FDA cleared)
3:00 – Yamanaka factors and why three genes beat four
6:00 – The breakthrough: ~75% age reversal, safely
11:00 – Make the body young enough and it cures itself
14:00 – Phase 1 safety and the path to approval
19:00 – The cost problem and realistic timeline
23:00 – NMN, NAD and sirtuins: the information theory of aging
28:00 – Cutting through longevity misinformation
30:00 – Testosterone, muscle mass, diet and sleep
40:00 – What comes after glaucoma, and a rejuvenation pill
44:00 – Sinclair's new Lifespan podcast and foundation

About Lifespan:
Dr. David Sinclair founded Lifespan to deliver clear, science-backed health insights that help people live longer, more vibrant lives.

He's now building the world's largest community dedicated to extending human longevity well beyond today’s limits. Join early access at lifespan.com.

New episodes of Lifespan with Dr. David Sinclair -- the #1 health and wellness podcast in its first season -- are now available on YouTube, Spotify, Apple Podcasts, and Lifespan.com.

Subscribe here: https://www.youtube.com/c/JamesAltucherShow/

Follow Me On Social
********************************

For media requests or interviews, please reach out to me at
altucher@gmail.com

Facebook
https://www.facebook.com/JAltucher.Blog/

Instagram
https://www.instagram.com/altucher/

Twitter
https://twitter.com/jaltucher
james altucher podcast, Altucher Report, podcast, comedy, altucher,